[1] |
World Health Organization . Forty-fourth world health assembly, resolutions and decisions. Geneva: World Health Organization, 1991.
|
[2] |
Dye C, Watt CJ, Bleed DM , et al. Evolution of tuberculosis control and prospects for reducing tuberculosis incidence, prevalence, and deaths globally. JAMA, 2005,293(22):2767-2775.
doi: 10.1001/jama.293.22.2767
URL
|
[3] |
World Health Organization . Implementing the WHO Stop TB strategy.A handbook for national TB control programmes. Geneva: World Health Organization, 2008.
URL
pmid: 26269864
|
[4] |
World Health Organization . The end TB strateny: global strategy and targets for tuberculosis prevention, care and control after 2015. Geneva: World Health Organization, 2015.
|
[5] |
World Health Organization . Roadmap for Childhood tuberculosis: toward zero deaths. Geneva: World Health Organization, 2013.
|
[6] |
World Health Organization . Guidance for national tuberculosis programmes on the management of tuberculosis in children. 2nd ed. Geneva: World Health Organization, 2014.
URL
pmid: 17131777
|
[7] |
World Health Organization . Childhood TB training toolkit. Geneva: World Health Organization, 2014.
|
[8] |
World Health Organization . Guidance for national tuberculosis programmes on the management of tuberculosis in children. Geneva: World Health Organization, 2006.
URL
pmid: 17131777
|
[9] |
World Health Organization . Ethambutol efficacy and toxicity: literature review and recommendations for daily and intermittent dosage in children. Geneva: World Health Organization, 2006.
|
[10] |
Donald P, Maher D, Qazi S , et al. A research agenda for childhood tuberculosis. Geneva: World Health Organization, 2007.
|
[11] |
World Health Organization . Treatment of tuberculosis in children: rapid advice. Geneva: World Health Organization, 2010.
|
[12] |
World Health Organization . Using the Xpert MTB/RIF assay to detect pulmonary and extrapulmonary tuberculosis and rifa-mpicin resistance in adults and children. Geneva: World Health Organization, 2013.
|
[13] |
World Health Organization . Xpert MTB/RIF assay for the diagnosis of pulmonary and extrapulmonary TB in adults and children: policy update. Geneva: World Health Organization, 2014.
|
[14] |
World Health Organization . The use of delamanid in the treatment of multidrug-resistant tuberculosis in children and adolescents: interim policy guidance. Geneva: World Health Organization, 2016.
|
[15] |
World Health Organization , UNICEF. Statement on the use of child-friendly fixed-dose combinations for the treatment of TB in children. Geneva: World Health Organization, 2017.
|
[16] |
World Health Organization . Guidelines on the management of latent tuberculosis infection. Geneva: World Health Organization, 2015.
doi: 10.1136/thoraxjnl-2012-201587
URL
pmid: 25973515
|
[17] |
World Health Organization . Recommendations for investigating contacts of persons with infectious tuberculosis in low- and middle-income countries. Geneva: World Health Organization, 2012.
|
[18] |
Boehme CC, Nabeta P, Hillemann D , et al. Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med, 2010,363(11):1005-1015.
doi: 10.1056/NEJMoa0907847
URL
|
[19] |
World Health Organization . The use of lateral flow urine lipoarabinomannan assay (LF-LAM) for the diagnosis and screening of active tuberculosis in people living with HIV. Geneva: World Health Organization, 2015.
|
[20] |
World Health Organization . The use of loop-mediated isothermal amplification (TB-LAMP) for the diagnosis of pulmonary tuberculosis: policy guidance. Geneva: World Health Organization, 2016.
|
[21] |
World Health Organization . The use of molecular line probe assays for the detection of resistance to isoniazid and rifampicin. Geneva: World Health Organization, 2016.
|
[22] |
World Health Organization . The use of molecular line probe assays for the detection of resistance to second-line anti-tuberculosis drugs: policy guidance. Geneva: World Health Organization, 2016.
|
[23] |
Falzon D, Schünemann HJ, Harausz E , et al. World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update. Eur Respir J, 2017, 49(3). pii: 1602308.
doi: 10.1183/13993003.02308-2016
URL
pmid: 5399349
|
[24] |
Trunz BB, Fine P, Dye C . Effect of BCG vaccination on childhood tuberculous meningitis and miliary tuberculosis worldwide: a meta-analysis and assessment of cost-effectiveness. Lancet, 2006,367(9517):1173-1180.
doi: 10.1016/S0140-6736(06)68507-3
URL
|
[25] |
World Health Organization . Global tuberculosis programme and global programme on vaccines. Statement on BCG revaccination for the prevention of tuberculosis. Wkly Epidemiol Rec, 1995,70(32):229-231.
|
[26] |
Becerra MC, Franke MF, Appleton SC , et al. Tuberculosis in children exposed at home to multidrug-resistant tuberculosis. Pediatr Infect Dis J, 2013,32(2):115-119.
doi: 10.1097/INF.0b013e31826f6063
URL
pmid: 22926210
|